On Tuesday, Following U.S. Stocks were among the “Top Gainers”:Stage Stores, (NYSE:SSI), DARA BioSciences, (NASDAQ:DARA), Meru Networks, (NASDAQ:MERU)

• Stage Stores, (NYSE:SSI), with shares inclined 3.89%, closed at $21.88.

• DARA BioSciences, (NASDAQ:DARA), with shares jumped 3.53%, settled at $0.88.

• Meru Networks, (NASDAQ:MERU), with shares climbed 3.12%, and closed at $1.65.

Latest NEWS regarding these Stocks are depicted underneath:

Stage Stores Inc. (NYSE:SSI)

Stage Stores Inc. (SSI), stated financial results for the fourth quarter and fiscal year ended January 31, 2015.

Fourth Quarter Stated Results:

Sales raised 6.6% to $524.9 million contrast to $492.5 million in the preceding year period. Comparable sales raised 6.4%. Three stores opened and four stores closed during the quarter. Net revenue from ongoing operations was $43.8 million or $1.36 per diluted share.

Full Year Stated Results:

Sales raised 1.8% to $1,639 million contrast to $1,609 million in the preceding year period. Comparable sales raised 1.4%. Eighteen stores opened and twelve stores closed during the year. Net revenue from ongoing operations was $37.9 million or $1.18 per diluted share.

2015 Guidance:

• Sales are predictable to be in a range of $1,640-$1,675 million, assuming a flat to 2% raise in comparable sales. The Corporation plans to open two stores and close 10-20 stores.
• Earnings per diluted share are predictable to be in a range of $1.20- $1.28.
• Weighted average diluted shares for the year are predictable to be 32.7 million. The effective tax rate is estimated to be 37.6%.
• Capital expenditures net of construction allowances from landlords for 2015 are predictable to be $75 million, contrast to $65 million in 2014.

Stage Stores, Inc. operates as a specialty department store retailer in the United States. The corporation operates its stores under the nameplates of Bealls, Goody’s, Palais Royal, Peebles, and Stage.

DARA BioSciences, Inc (NASDAQ:DARA)

DARA BioSciences, Inc (DARA), an oncology supportive care specialty pharmaceutical corporation dedicated to providing healthcare professionals a synergistic portfolio of medicines to assist cancer patients adhere to their therapy and manage side effects arising from their cancer treatments, declared that it has finalized a Commercialization Contract with Onxeo S.A., an innovative corporation specializing in the development of orphan oncology drugs, granting DARA the U.S. rights to Oravig®, the first and only orally-dissolving buccal tablet approved for oral thrush. DARA has contemporaneously executed a co-promotion contract with Mission Pharmacal Corporation, a privately held pharmaceutical corporation based in San Antonio, Texas, to co-promote Oravig in the primary care market.

Under the terms of the Contract, DARA will attain the approved New Drug Application (NDA) and will have the exclusive rights to market and sell Oravig in the United States. DARA also has the right to pursue regulatory approval in Canada which, if granted, would give DARA exclusive rights to market and sell Oravig there. DARA will book all proceeds on Oravig and will pay Onxeo S.A. certain milestone payments upon the achievement of defined sales thresholds; DARA has additionally undertaken to complete a pediatric study as part of a post-marketing commitment, which if successful, may provide DARA with both an expanded indication and market size for Oravig.

DARA BioSciences, Inc., a development stage biopharmaceutical corporation, develops and commercializes oncology treatment and supportive care pharmaceutical products in the United States.

Meru Networks, Inc. (NASDAQ:MERU)

Meru Networks, Inc. (MERU), a leader in intelligent Wi-Fi networking, declared that Bishop O’Dowd High School, a private Catholic college preparatory school, has deployed a Meru wireless network to address the growing number of wireless devices on campus. Meru Wi-Fi will support about 1,200 students and 125 staff — many of whom use multiple mobile devices — across eight buildings located on seven-and-a-half acres. The school has begun a migration to Meru’s 802.11ac solution.

Bishop O’Dowd is regarded as one of the most prestigious private schools in Northern California. Offering a bring your own device (BYOD) program to ensure students develop the expertise to utilize technology effectively, Bishop O’Dowd prides itself on providing students with the proper resources and technology to further their education.

The school, which formerly relied on Cisco Wi-Fi, selected Meru Wi-Fi after facing challenges with 802.11b devices and balancing channels in a dense environment. Drop-offs and unreliable signals with access points across campus ultimately led Bishop O’Dowd to lean on Meru and its MobileFLEX architecture with Virtual Cell technology to effectively address these issues.

Bishop O’Dowd is now able to support any device that a student brings to campus, and is leveraging the Meru wireless network for education, athletics and for the school’s Wi-Fi cameras.

Meru Networks (NASDAQ: MERU) is a leader in intelligent 802.11ac Wi-Fi solutions delivering uninterrupted user experience for education, healthcare, hospitality and enterprise. The Meru open-standards-based architecture is designed to enable unified administration of wired and wireless networks. Its end-to-end application QoS enables enforceable service-level contracts. Meru provides top performance and high capacity in high-density environments.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content described in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.